603392 萬泰生物
按盤價 
46.780 +0.100 (+0.214%) | 2025/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 1,498,370 | -23.09% | 2,245,403 | 5,510,783 | 11,185,189 | 5,750,329 | |
| 減：營業總成本 | 1,780,002 | -7.72% | 2,395,621 | 3,878,717 | 5,747,909 | 3,404,115 | |
| 其中:營業成本 | 695,514 | 11.33% | 759,045 | 873,242 | 1,170,412 | 817,711 | |
| 財務費用 | (11,342) | -72.87% | (58,068) | (92,977) | (61,612) | 5,195 | |
| 資產減值損失 | (16,894) | 59.56% | (103,626) | (459,733) | (20,503) | (29,841) | |
| 公允價值變動收益 | 23,076 | 73.03% | 36,707 | 24,657 | 9,977 | 28 | |
| 投資收益 | 66,511 | -28.83% | 109,636 | 98,898 | 36,113 | 11,225 | |
| 其中：對聯營企業和合營企業的投資收益 | -- | -- | -- | -- | -- | -- | |
| 營業利潤 | (184,442) | -169.74% | 93,838 | 1,401,451 | 5,596,038 | 2,328,456 | |
| 利潤總額 | (191,856) | -177.94% | 67,481 | 1,393,392 | 5,582,691 | 2,324,145 | |
| 減：所得稅費用 | (17,965) | -26.17% | (41,614) | 146,887 | 719,390 | 244,931 | |
| 淨利潤 | (173,891) | -164.29% | 109,095 | 1,246,504 | 4,863,301 | 2,079,214 | |
| 減：非控股權益 | (469) | -112.23% | 2,859 | (1,175) | 127,506 | 57,747 | |
| 股東淨利潤 | (173,422) | -165.04% | 106,235 | 1,247,680 | 4,735,795 | 2,021,468 | |
市場價值指標 | |||||||
| 每股收益 (元) * | -0.140 | -166.67% | 0.080 | 0.990 | 3.790 | 2.300 | |
| 每股派息 (元) * | -- | -- | -- | 0.320 | 1.000 | 0.200 | |
| 每股淨資產 (元) * | 9.556 | -2.69% | 9.693 | 10.015 | 13.621 | 7.357 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 09/01/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
